Curanex Pharmaceuticals CURX
NASDAQ CURX
$4.99 -0.02 (-0.40%)
As of: Oct 22, 2026 · 9:48 AM EDT

Curanex Pharmaceuticals (CURX) Non-Current Debt (2025)

Updated

Curanex Pharmaceuticals (CURX) reported Non-Current Debt of $400,000 for Q2 2025.

Analysis

Curanex Pharmaceuticals (CURX) Non-Current Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,166.70 Bn 1,135.28 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 633.99 Bn 552.52 Bn 17.26 Bn 37.34 Bn
3 AbbVie 502.96 Bn 476.07 Bn 12.70 Bn 62.48 Bn
4 Merck 377.09 Bn 331.47 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 303.78 Bn 267.77 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 266.66 Bn 240.35 Bn 12.86 Bn 23.68 Bn
7 Amgen 241.39 Bn 196.79 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 23.83 Bn
9 Pfizer 172.37 Bn 119.01 Bn 10.94 Bn 60.50 Bn
10 Curanex Pharmaceuticals 7.08 Mn -6.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 400,000.00
API Access

Curanex Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=CURX&period=max&api_key=YOUR_API_KEY